Conference abstract · 26 Sep 2017
Conference abstractPublished 8 Dec 2016
Immunological non responder′s real or virtual phenomenon
B.P. Koirala Institute of Health Sciences, Nepal
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Statement of the Problem: HIV and Hepatitis C viral Infection (HCV) have same mode of transmission. A subset of HIV people on antiretroviral therapy (ART) achieves virological suppression but poor recovery of CD4 cell termed as immunological nonresponders. It has been recommended to start HCV treatment in HIV co-infection if CD4 cells are more than 200/ml. Immunological non-responders could be a challenge to initiate HCV treatment especially in limited resources setting. Case Description: A 24 years intravenous drug abuser male with HCV for last three years presented as HIV positive (CD4-186/ml) on July 2008. Despite ZDV/3TC/EFV for six months he did not achieve immunological recovery but his viral load was below 400 copies per ml. On September 2009 he presented with fever and constitutional symptoms for two weeks. On examination he was pale, icteric and had hepatospleenomegaly. Investigation revealed pancytopenia, transaminitis, hepatospleenomegaly, sterile blood culture, normal chest X-ray, sputum for acid fast bacilli and PCR for Mycobacterium tubercle negative, negative rK-39, malaria negative. He had CD4 of 156/ml, HIV viral load 72 copies per ml and HCV RNA 15600 copies per ml. Bone marrow aspiration revealed 3+ Leishmania donovani (LD) bodies. ARV regimen was changed to TDF/3TC/EFV and tablet Miltefosine 50 mg twice a day for 28 days was initiated. He improved clinically and parasitologically. On April 2010 his second infection of Visceral Leishmaniasis (VL) was treated with injection Amphotericin B. On March 2011 and August 2012 he had third and fourth episode of VL infection and was treated with Amphotericin B plus Miltefosine and liposomal Amphotericin B respectively. However the fourth episode was continued with secondary prophylaxis for six months with immunological recovery (CD4 756/ml). On April 2015 his HCV was treated with 12 weeks Sofosbuvir and Daclatasvir with Rapid Viral and Sustained Viral Response. Significance: Immunological non responders might be virtual phenomena.
Subjects
Infectious DiseasesAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Conference abstract · 24 Feb 2020
An inbuilt real-time check for mask fit and respirator protection for healthcare workers and emergency responders
Opinion · 2017
A Mysterious Phenomenon in the Field of Contemporary Immunology
Article · 2014
A preliminary study of CD150 expression in responders and non- responders to the Hepatitis B vaccine.
Conference abstract
Transcription level of ifnar1 and socs1 in patients infected with Hepatitis C Virus responders and non-responders to the IFN-alpha treatment
More from this journal
The newest in Journal of Infectious Diseases & Therapy.
Research article · 14 Apr 2026
Ethiopian Child Immunization Coverage Prevalence and Determinants: Evidence from the 2019 Mini-Demographic and Health Survey
Research article · 5 May 2025
The Ultimate Cure for the COVID Syndemic
Mini review · 29 Apr 2025
COVID-19 Systematic Mini-Review as of April 2025
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Infectious Diseases & Therapy
- SubjectInfectious Diseases
- BylineArticles whose byline prints “Vivek Kattel”
- BylineArticles whose byline prints “B Pradhan”
- BylineArticles whose byline prints “P Karki”
- BylineArticles whose byline prints “S Rijal”
- BylineArticles whose byline prints “S Pandey”
- BylineArticles whose byline prints “B Khanal”
- BylineArticles whose byline prints “Y Agrawal”
